GeneID: 353



Names

Common Name: HDAC1 Type: Gene
Chromosome: 1 (NC_000001.11) Locus: NG_047018.1 (HDAC1)
HUGO Symbol: HDAC1 Full Name: histone deacetylase 1
Exons: 14 Introns: 13

Description:
The protein encoded by this gene belongs to the histone deacetylase (HDAC) family. Members of this family participate in large complexes that act to regulate gene transcription via modification of acetylation marks on lysine residues in histones. Removal of the acetyl groups facilitates tighter packing of chromatin (heterochromatin formation) leading to transcriptional repression. HDAC1 belongs to the class I HDACs (HDSC1, 2, 3, and 8), which are expressed in most cell types with key roles in cellular differentiation and developmental processes. HDAC1 forms part of the NuRD (nucleosome remodelling and deacetylating) complex, which is implicated in HbF control. Inhibition of HDAC1 activates fetal γ-globin gene expression in human adult erythroid cells. The p38 MAPK signalling pathway and GATA2 erythroid transcription factor are implicated in HDAC inhibition-mediated γ-globin induction. HDAC inhibitor drugs hold great promise for the treatment of sickle cell disease and beta-thalassaemia.

Synonyms: HD1 , RPD3 , KDAC1 , GON-10 , RPD3L1

Comments:
N/A

Sequence Viewer

Note: The NCBI Sequence Viewer is not installed on the ITHANET servers but it is embedded in this page from the NCBI. Therefore, IthaGenes has no responsibility over any temporary unavailability of the service. In such a case, please Refresh the page or retry at a later stage.

Publications / Origin

  1. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB, Histone deacetylases (HDACs): characterization of the classical HDAC family., Biochem. J., 370(0), 737-49, 2003 PubMed
  2. Witt O, Monkemeyer S, Rönndahl G, Erdlenbruch B, Reinhardt D, Kanbach K, Pekrun A, Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin., Blood, 101(5), 2001-7, 2003 PubMed
  3. Johnson J, Hunter R, McElveen R, Qian XH, Baliga BS, Pace BS, Fetal hemoglobin induction by the histone deacetylase inhibitor, scriptaid., Cell. Mol. Biol. (Noisy-le-grand), 51(2), 229-38, 2005 PubMed
  4. Bradner JE, Mak R, Tanguturi SK, Mazitschek R, Haggarty SJ, Ross K, Chang CY, Bosco J, West N, Morse E, Lin K, Shen JP, Kwiatkowski NP, Gheldof N, Dekker J, DeAngelo DJ, Carr SA, Schreiber SL, Golub TR, Ebert BL, Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease., Proc. Natl. Acad. Sci. U.S.A., 107(28), 12617-22, 2010 PubMed
  5. Esrick EB, McConkey M, Lin K, Frisbee A, Ebert BL, Inactivation of HDAC1 or HDAC2 induces gamma globin expression without altering cell cycle or proliferation., Am. J. Hematol., 90(7), 624-8, 2015 PubMed
  6. Shearstone JR, Golonzhka O, Chonkar A, Tamang D, van Duzer JH, Jones SS, Jarpe MB, Chemical Inhibition of Histone Deacetylases 1 and 2 Induces Fetal Hemoglobin through Activation of GATA2., PLoS ONE, 11(4), e0153767, 2016 PubMed
  7. Mettananda S, Yasara N, Fisher CA, Taylor S, Gibbons R, Higgs D, Synergistic silencing of α-globin and induction of γ-globin by histone deacetylase inhibitor, vorinostat as a potential therapy for β-thalassaemia., Sci Rep, 9(1), 11649, 2019 PubMed
Created on 2020-01-13 15:15:32, Last reviewed on (Show full history)


Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.